Clinical trial
LuCaReAl: Lung Cancer Registry in Algeria.
NCT02725892 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LuCaReAl: Lung Cancer Registry in Algeria.
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 19, 2016
- Completion date
- February 28, 2021
- Enrollment
- 897 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
oncology & epidemiology & lung cancer